Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Bruun Rovsing

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Scandinavian Journal of Immunology|July 29, 2025
Multiparametric Optimization of Human Primary B-Cell Cultures Using Design of ExperimentsAnne Bruun Rovsing, Kenneth Green, Lisbeth Jensen, et al.
British Journal of Haematology|May 16, 2023
Resistance to vincristine in DLBCL by disruption of p53-induced cell cycle arrest and apoptosis mediated by KIF18B and USP28Anne Bruun Rovsing, Emil Aagaard Thomsen, Ian Nielsen, et al.
Molecular Oncology|June 26, 2020
Identification of BLNK and BTK as mediators of rituximab-induced programmed cell death by CRISPR screens in GCB-subtype diffuse large B-cell lymphomaEmil Aagaard Thomsen, Anne Bruun Rovsing, Mads Valdemar Anderson, et al.
The Journal of Allergy and Clinical Immunology|June 10, 2023
Restriction of C1-inhibitor activity in hereditary angioedema by dominant-negative effects of disease-associated SERPING1 gene variantsLaura Barrett Ryø, Didde Haslund, Anne Bruun Rovsing, et al.
Molecular Therapy. Nucleic Acids|September 27, 2024
Cell-targeted gene modification by delivery of CRISPR-Cas9 ribonucleoprotein complexes in pseudotyped lentivirus-derived nanoparticlesIan Helstrup Nielsen, Anne Bruun Rovsing, Jacob Hørlück Janns, et al.
Nucleic Acids Research|September 7, 2023
Engineered lentivirus-derived nanoparticles (LVNPs) for delivery of CRISPR/Cas ribonucleoprotein complexes supporting base editing, prime editing and in vivo gene modificationJakob Haldrup, Sofie Andersen, Alexander Rafael LaVilla Labial, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Scandinavian Journal of Immunology|July 29, 2025
Multiparametric Optimization of Human Primary B-Cell Cultures Using Design of ExperimentsAnne Bruun Rovsing, Kenneth Green, Lisbeth Jensen, et al.
British Journal of Haematology|May 16, 2023
Resistance to vincristine in DLBCL by disruption of p53-induced cell cycle arrest and apoptosis mediated by KIF18B and USP28Anne Bruun Rovsing, Emil Aagaard Thomsen, Ian Nielsen, et al.
Molecular Oncology|June 26, 2020
Identification of BLNK and BTK as mediators of rituximab-induced programmed cell death by CRISPR screens in GCB-subtype diffuse large B-cell lymphomaEmil Aagaard Thomsen, Anne Bruun Rovsing, Mads Valdemar Anderson, et al.
The Journal of Allergy and Clinical Immunology|June 10, 2023
Restriction of C1-inhibitor activity in hereditary angioedema by dominant-negative effects of disease-associated SERPING1 gene variantsLaura Barrett Ryø, Didde Haslund, Anne Bruun Rovsing, et al.
Molecular Therapy. Nucleic Acids|September 27, 2024
Cell-targeted gene modification by delivery of CRISPR-Cas9 ribonucleoprotein complexes in pseudotyped lentivirus-derived nanoparticlesIan Helstrup Nielsen, Anne Bruun Rovsing, Jacob Hørlück Janns, et al.
Nucleic Acids Research|September 7, 2023
Engineered lentivirus-derived nanoparticles (LVNPs) for delivery of CRISPR/Cas ribonucleoprotein complexes supporting base editing, prime editing and in vivo gene modificationJakob Haldrup, Sofie Andersen, Alexander Rafael LaVilla Labial, et al.
Pageof 1